Literature DB >> 18657874

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.

Huan Xu1, Yihui Deng, Dawei Chen, Weiwei Hong, Yi Lu, Xiaohui Dong.   

Abstract

To make vesicles for the better controlled content release, we modified cholesteryl hemisuccinate (CHEMS)-derived vesicles with PEG-lipid derivatives. Two cholesterol analogs, cholesteryl hemisuccinate (CHEMS) and cholesteryl chloroformate (CHM), have been conjugated to the polyethylene glycol (PEG) via their ester bonds for the vesicle modifications, so the PEGs can be cleaved by esterases. The effects of PEG-lipid proportions, serum concentrations and the lipid types on the esterase-catalyzed cleavage of PEG polymer off the vesicles surface were determined. We observed that PEG cleavages decreased as the molar ratios of the PEG-lipids in vesicles increased; on the other hand, PEG cleavages gradually increased with the increased serum concentrations. In contrast to conventional long circulation materials mPEG-DSPE and mPEG-CHOL, the two new conjugates enabled higher degrees of PEG cleavages from modified vesicles. After incubation in the serum at acidic conditions, esterase-catalyzed dePEGylation destabilized these vesicles, increasing the mean particle sizes and promoting content releases. These results suggested that ester linkages between the PEG and lipid anchors allow faster content releases in the suitable conditions. Together, the two esterase cleavable PEG-lipid conjugations may be applied not only to stabilize vesicles and prolong their circulation time, but also to provide more efficient content releases by the esterase controlled dePEGylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657874     DOI: 10.1016/j.jconrel.2008.05.009

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 2.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Authors:  Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Adv Drug Deliv Rev       Date:  2011-05-03       Impact factor: 15.470

3.  Preparation and characterization of stable pH-sensitive vesicles composed of α-tocopherol hemisuccinate.

Authors:  Huan Xu; Yi-Hui Deng; Kai-Qian Wang; Da-Wei Chen
Journal:  AAPS PharmSciTech       Date:  2012-10-03       Impact factor: 3.246

Review 4.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

5.  Stoichiometry and Kinetics of Sequential Dimethacrylate Enzymolysis.

Authors:  S Frukhtbeyn; K Van Dongen; J Sun
Journal:  J Dent Res       Date:  2019-08       Impact factor: 6.116

Review 6.  Targeted delivery of nano-therapeutics for major disorders of the central nervous system.

Authors:  Huile Gao; Zhiqing Pang; Xinguo Jiang
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

7.  Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.

Authors:  Shuangshuang Song; Fen Chen; Huan Qi; Fei Li; Tiegang Xin; Jingwen Xu; Tiantian Ye; Naicheng Sheng; Xinggang Yang; Weisan Pan
Journal:  Pharm Res       Date:  2013-10-24       Impact factor: 4.200

8.  [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction.

Authors:  Vahid Serpooshan; Senthilkumar Sivanesan; Xiaoran Huang; Morteza Mahmoudi; Andrey V Malkovskiy; Mingming Zhao; Mohammed Inayathullah; Dhananjay Wagh; Xuexiang J Zhang; Scott Metzler; Daniel Bernstein; Joseph C Wu; Pilar Ruiz-Lozano; Jayakumar Rajadas
Journal:  Biomaterials       Date:  2014-10-13       Impact factor: 12.479

9.  The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape.

Authors:  Huan Xu; Wei Zhang; Yan Li; Fei F Ye; Peng P Yin; Xiu Yu; Mei N Hu; Yuan S Fu; Che Wang; De J Shang
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

10.  Localized SDF-1α Delivery Increases Pro-Healing Bone Marrow-Derived Cells in the Supraspinatus Muscle Following Severe Rotator Cuff Injury.

Authors:  L E Tellier; J R Krieger; A L Brimeyer; A C Coogan; A A Falis; T E Rinker; A Schudel; S N Thomas; C D Jarrett; N J Willett; E A Botchwey; J S Temenoff
Journal:  Regen Eng Transl Med       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.